| Korean pavilion H7.G50 |
Meet and collaborate with a range of excellent and pioneering medical device companies
Health Industry Development Institute (KHIDI), a government organization associated with Ministry of Health and Welfare in Korea, will hold the “KOREA MED-TECH EXPERIENCE PAVILION” at Arab Health from January 30 to February 2, 2023.
Visit the KOREA MED-TECH EXPERIENCE PAVILION to view and experience the excellent quality of Korean medical devices. You are invited to collaborate with the Korean medical device companies who are seeking partners to grow their businesses through one-to-one business meetings during Arab Health 2023.
Nine companies will be showcasing their medical products in the fields of surgery, diagnostics and medical imaging. Five of the companies were selected by the Korean Government because of their pioneering medical technology that will advance healthcare.
KHIDI is actively promoting and supporting the marketing of these innovative medical device companies in an effort to firmly establish the sector in Korea.
KHIDI looks forward to seeing you at pavilion H7.G50 during Arab Health 2023.
Contact Secretariat of KOREA MED-TECH EXPERIENCE PAVILION of the KHIDI Email: yoon123@khidi.or.kr Website: www.khidi.or.kr/device |
DEEP BIO to showcase expertise in learning and cancer pathology
Deep Bio Inc. is an AI healthcare company with in-house expertise in deep learning and cancer pathology.
The company was founded in 2015 with the transformative mission: To advance patient outcomes by driving innovation in technology, while empowering clinicians by providing the tools to make critical decisions.
Deep Bio envisions a world where clinicians are empowered with technology designed to unlock personalized insights and enhance healthcare delivery, so they can focus more on what they do best: Caring for their patients.
As a first step towards this goal, Deep Bio strives to radically improve efficiency and accuracy of pathologic cancer diagnosis and prognosis by equipping pathologists with deep learning-based IVD SaMDs (In Vitro Diagnostics Software as a Medical Device), for optimal cancer treatment decisions.
DeepDx Prostate
DeepDx Prostate detects and highlights areas of interest on prostate needle biopsy whole slide images (WSIs). It provides various automated metrics for more accurate and consistent results and facilitates faster pathology workflow. In a clinical validation, its performance was demonstrated to provide specialist-level support to pathologists.
DeepDx Prostate: Clinically-validated & CE marked AI software for prostate cancer
Key Features
- Coloured overlays for each Gleason pattern at the gland-level: Pattern 3, Pattern 4, Pattern 5
- Tumour & Pattern Quantification: The proportion of each Gleason pattern out of the total tumour area and tumour-to-tissue ratio quantified automatically
- Auto Length Measurement: Automatic measurements of total tissue and total tumour lengths
- Use cases First Read Concurrent read
- Quality control and R&D
- Real world tested
- Deployed in US CLIA labs, successful analysis of 700K+ core biopsy images between 2019 and 2021.
- To learn more, visit www.deepbio.co.kr. email: sales@deepbio.co.kr
Neurosona specialises in development of focused ultrasound devices for treatment of brain diseases
Neurosona, established in 2017, has a research support agreement with the Brigham and Women’s Hospital (BWH) of Harvard Medical School and is leading the world in research and development of low-intensity focused ultrasound devices for treatment of brain diseases.
Based on the differentiated brain stimulation technology, Neurosona is conducting clinical trials on brain diseases including major depressive disorder, Alzheimer’s disease, neuropathic pain, disorders of consciousness, sleep disorders, and stroke recovery in specific areas of the entire brain, including the deep brain.
Image-guided low-intensity focused ultrasound technology
Neurosona’s low-Intensity focused ultrasound technology accurately transmits low-intensity acoustic energy with low heat generation from the brain cortex to the deep brain for neuromodulation or blood-brain barrier opening in specific brain areas. Since it hardly generates any heat, the technology is relatively safe and it can accurately stimulate specific areas, including the deep brain.
Ultrasound stimulator system
Neurosona has developed the low-Intensity focused ultrasound stimulator system (NS-US series) for application of non-invasive interventions of brain diseases, such as major depressive disorder and Alzheimer’s disease, by precisely stimulating specific areas of the whole brain, including the brain cortex and deep brain with the low-intensity focused ultrasound of less than 250 kHz that has been proven to be safe.
Neurosona’s focused ultrasound stimulation system enables good access to the deep brain for treatment. In addition, since this system offers ultrasound according to parameters optimized for target diseases, it can provide patient-customized precise stimulation for local areas of the whole brain. Based on these advantages, Neurosona continued to improve the ease of use of this system for patients and doctors.
Neurosona’s low-intensity focused ultrasound stimulation system NS-US200 was designated as an innovative medical device in August 2021 in recognition of its innovative technology and clinical improvement potential by the Korean Ministry of Food and Drug Safety.
- For more information, visit: www.neurosona.com Email: sales@neurosona.com
VUNO specialises in medical AI deep learning solutions
VUNO is a global leader in medical AI with a proven track record developing and commercializing medical AI deep learning solutions. VUNO strives to realize the possibilities of AI technology in medicine to improve quality of life for mankind.
Their goal is to develop and commercialize AI solutions that leverage a wide range of medical data including bio-signals, imaging, and digital pathology to detect and prevent disease early on.
Founded in 2014, VUNO was the first company to successfully obtain Korea FDA (MFDS) approval for medical AI software. Since then, VUNO has rapidly expanded its commercial presence and product portfolio to encompass a diverse and comprehensive line up of impactful and clinically relevant solutions.
With a proven R&D and commercial track record, including a history of success winning international technical challenges coupled with global deployments in over 500 hospitals, VUNO is an undisputed leader in the global medical AI arena.
- For more information, visit: youngsoo.park@vuno.co
Surginus develops new type of suture method
Since its establishment in 2020, Surginus Co., Ltd. has been developing and manufacturing products with the value of improving quality and patient centred technology.
For the first time in Korea, they have developed a product (Foldable Skin Closure) that uses a new type of suture method without using needles, threads and staples.
In addition, in order to make products that can give satisfaction to patients and medical staff, they are manufactured in a clean room (ISO 8, Class 10,000), and ‘ISO
13485:2016, FDA (Listing)’ has been acquired.
Surginus will continue to strive to increase its value in the future.
- For more information, visit: dhkim@surginus.com
LAON MEDI’s AI tech analyzes airflow to detect of obstructive sleep apnoea
LAON MEDI Inc. provides medical solutions based on AI (Artificial Intelligence) technology with a mission to create a happy world with technology.
Launched in 2018 by its parent company LAON PEOPLE Inc. (KOSDAQ-listed), it is a young company that was spun-off last year and established as a separate corporation.
Based on their achievements in Machine Vision, they have developed their own AI algorithms, and based on this, they have expanded their scope to transportation, agriculture, military, and medical and dental fields. AI is now a reality, not a field of study, and application in the medical industry is essential.
For more accurate diagnosis, LAON MEDI is researching and developing medical software that is convenient and useful in real life.
Obstructive sleep apnoea
LAON MEDI’s software is an AI technology that analyzes airflow in the airway based on the patient’s CT/CBCT imaging and determines whether there is obstructive sleep apnoea. This technology consists of a medical image derivation model that extracts upper airway features from CT images, a flow factor derivation model that predicts flow characteristics according to airway features, and a sleep apnoea severity diagnosis model that determines the severity of obstructive sleep apnoea from the patient’s ergonomic information.
Using this technology, it is possible to identify the morphological factors of the patient’s airway and quantitatively present the flow factors, air pressure in the airway and the degree of airway closure (strain rate). In addition, the derived factors help doctors make a final diagnosis by analyzing the possibility of obstructive sleep apnoea.
- For more information, visit: www.laon-medi.com Email: jhcho@laon-medi.com
FCU Ultrasound focuses on handheld ultrasound devices and probes
Founded in 2014, FCU Ultrasound specializes in developing and manufacturing handheld ultrasound devices and probes.
As a professional medical device manufacturer, FCU Ultrasound have ISO13485, KGMP, MFDS, CE, and FDA certification products.
They have maintained a high growth rate every year. And, in 2021, they recorded more than 70% growth year-on-year, and nearly 90% of their sales were exports.
FCU Ultrasound manufacture OEM transducers (single crystal, composite, bulk PZT, low-cost PZT) for a variety of applications with technology that meets the price and performance based on customers’ needs.
They are gradually expanding from OEM supply to their own branded products. In particular, the handheld ultrasound is equipped with a needle navigation solution for the first time in the world. Based on this, they hope to target the world market in earnest to create new business models with global companies in the digital healthcare field.
PC based needling training tool for ultrasound guided procedures, eZSimulator
Various training
• For training of the probe-needle coordination in real application scenarios
• The most intuitive tool to learn two hands eye coordination
Independent training
• Without the need of an ultrasound systems or special phantoms.
Procedure oriented ultrasound for safe procedures, for everyone.
World’s first handheld navigation ultrasound, SC1
KEY POINTS
- Best-in-class image quality
- Needle guidance system
- Easy to learn, easy to use
Needle Guidance System
By using magnetic sensors, SC1 recognizes and tracks a magnetized needle.
In-plane approach. Align confidently
- It is easy to perform the procedure while checking the alignment of the probe icon and needle on the screen.
- Through the guideline, you can check where the needle is currently located in the body.
Out-of-Plane approach. Just set the target, and inject
- While it is usually difficult to know the distance and depth from the needle to the target, SC1 allows you to know these prior to insert and to adjust the angle of the needle accordingly.
Procedure oriented ultrasound for safe procedures, for everyone.
- For more information, email: marketing@fcultrasound.com
Sunmedix’s portable & detachable pneumatic device helps prevent post-operative DVT
Established in 2004, Sunmedix Co., Ltd., specialises in manufacturing various kinds of medical devices, especially products related to surgical procedures.
Their mission is: “For the wholesome daily lives of our neighbours.”
Through constant brainstorming, Sunmedix realizes and customizes products based on their buyer’s needs. They export their products to more than 30 countries with ISO13485 and CE certifications.
Dcos DVT Prevention Pump System
Dcos is a portable and detachable pneumatic device with 3-cham- bers intended to prevent post-operative DVT (Deep Vein Throm- bosis). It delivers a sequential pneumatic pulse through an air cuff and stimulates blood circulation and reduces pain and swelling.
Dcos is a lightweight device weighing approximately 326 grams, which greatly enhances it convenience for the user.
The great advantage of Dcos is that it is not limited to use in the operation room or recovery room. It is free of obstructions compared to the bed-mounted type.
Sunmedix is supplying the world’s first E.O. sterile cuffs, which have has a great ripple effect in the market.
Gcos Bipolar Vessel Sealer
Gcos is a sterile single-use electrosurgical device used in coagulation (haemostasis) and incision of the blood vessels and tissues, to be connected to a medical electrosurgical generator unit. It reduces blood loss, procedure time and patient length of stay compared to sutures and clips.
Features:
- Ergonomic handle
- Freely rotatable shaft
- Safety system for blade operation & auto-lock function
- Soft cutting & less tissue damage
- Compatible with different electrosurgical generators
- Minimally invasive procedure: minimizing tissue damage and thermal injury
- Unique ergonomic design: eliminates deviation of the wrist, reduces carpal tunnel pressure and eradicates fatigue
- Efficient & precise surgery
Meerecompany develops surgical robots with advanced technology
meerecompany is a global company that focuses on innovation and aims to maximize the happiness of its customers, employees and shareholders. Since 1984, meerecompany has been responding to the rapidly changing technological environment and conducting research to usher in the innovations of the future.
Revo-i surgical robot
The Revo-i system is a safe and affordable surgical robot which utilizes the latest technologies with the aim of providing better care to more patients anywhere around the world.
Features of the Revo-i system include: informative imaging, intuitive control, advanced devices and virtual training.
Since 2007, meerecompany has continuously strived to reflect the voices and opinions of medical professionals, while also taking into consideration the difficulties of managing a hospital with dynamic surgical environments.
meerecompany’s focus is to reduce this burden by making an affordable surgical robotic device and delivering a reliable product with high-level service from their professional care team.
meerecompany strives to offer an excellent programme that synergizes with hospitals, surgeons, patients and corporations.
Introducing Revo-i
Master Console
The Master Console is the Revo-i surgical robotic system’s control centre. A surgeon
can issue commands to the master console located outside of the sterilized area by controlling the instrument with 3DHD vision during the surgery.
Operation Cart
The Operation Cart assists surgeons in performing surgeries with the use of Revo-i free-wrist instruments and a 3D endoscope camera while minimizing tremors and micro-movements.
Vision Cart
The Vision Cart enables surgeons to clearly visualize the overall process of the surgery. The Revo-i image processing system delivers surgical images for surgeons and OR staff to help them communicate better.
- For more information, email: info@revosurgical.com
LIVSMED’s laparoscopic medical instruments enable precision surgery
LIVSMED, established in June 2011, is a medical device company specializing in laparoscopic devices. Their goal and vision is to lead the global medical device industry with their unique products beginning with ArtiSential, their multi-joint, multi-DOF laparoscopic instrument that allows 360-degree movement in laparoscopy and overcomes the various limitations of existing straight type instruments and surgical robots.
Approved by the Korean FDA in 2018, LIVSMED has received awards for its innovative technology and contribution to public welfare, as well as being chosen as “Innovative Medical Device Company” by the Korean Ministry of Health and Welfare in 2020. LIVSMED strives to contribute to life extension and overall healthcare of all mankind by creating innovative products while adhering to the highest ethics. LIVSMED’s mission is to bring surgery with precision to the hands of doctors, one patient at a time.
ArtiSential: The innovative next- generation surgical instrument
ArtiSential is a disposable laparoscopic medical instrument usable in all minimally invasive surgeries including gastrointesti- nal, thoracic, hepato-pancreatic, colorec- tal surgeries and others.
ArtiSential is characterized by its total 360 degrees of freedom and intuitiveness, which distinguishes it from existing straight-line instruments and their limited movement. ArtiSential’s multi-jointed end-effector provides surgeons with precise control which is essential for accessing narrow surgical sites and performing with dexterity in laparoscopy. In addition, ArtiSential’s end-tool moves in synchronization with the user’s hand motions. Its intuitive control provides much higher ease of use.
ArtiSential’s end-tool functions similarly to that of a surgical robot, since the instrument moves in all directions smoothly with the help of its multi-jointed technology.
ArtiSential is a hand-held device which can be used in existing surgical environments without any additional devices.
This is advantageous in aspects of cost-effectiveness and efficiency.
The company has a variety of end-tool types (e.g. forceps/grasper, needle holder, dissector, hook, spatula, clip applier, etc.), selectable by surgical need or users’ comfort.
ArtiSential’s products come in various lengths (25cm, 38cm, 45cm) and sizes (5mm, 8mm). Some types have bipolar/ monopolar energy options.
- For more information, visit: www.livsmed.com Email: info@livsmed.com
